TTD Drug ID: DAP000522

Drug Information
Name	Gliclazide
Synonyms	KBio1_001910; 1-(3-Azabicyclo(3.3.0)oct-3-yl)-3-(p-tolylsulfonyl)urea; N-[(hexahydrocyclopenta[c]pyrrol-2(1H)-ylamino)carbonyl]-4-methylbenzenesulfonamide; 1-(Hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)urea; S 1702; Diamicron; SMR000542971; DB01120; STK803142; NCGC00095107-01; Gliclazidum [INN-Latin]; KBio2_004526; S-1702; Gliclazida [INN-Spanish]; AB1004595; SPECTRUM1505013; Urea, 1-(hexahydrocyclopenta(c)pyrrol-2(1H)-yl)-3-(p-tolylsulfonyl)-; KBio2_001958; BRD-A61154809-001-04-3; 1-(3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl)-3-(4-methylphenyl)sulfonylurea; NCGC00095107-02; LS-160299; Spectrum_001478; Gliclazide [BAN:INN:DCF:JAN]; SPBio_002556; KBioGR_001096; N-(hexahydrocyclopenta[c]pyrrol-2(1H)-ylcarbamoyl)-4-methylbenzenesulfonamide; S-852; Prestwick3_000558; Prestwick2_000558; Diaikron; KBio2_007094; Nordialex; C15H21N3O3S; MolPort-002-507-779; 21187-98-4; SPECTRUM1504145; MLS001304118; AC1L1G0Q; NCGC00095107-03; KBio3_002806; Prestwick0_000558; EINECS 244-260-5; BPBio1_000699; Gliclazidum; AB00053165; N-(4-Methylbenzenesulfonyl)-N'-(3-azabicyclo(3.3.0)oct-3-yl)urea; Glimicron (TN); G2167_SIGMA; HMS2090K16; 1-(3-Azabicyclo[3.3.0]oct-3-yl)-3-p-tolylsulphonylurea; BRN 1657836; SE 1702; NCGC00095107-04; NCGC00095107-05; Spectrum4_000598; CHEMBL427216; MLS001215197; Spectrum5_000753; Gliclazida; KBioSS_001958; BSPBio_000635; CID3475; Gliklazid; D01599; AC-12045; Prestwick_869; Spectrum3_001862; BSPBio_003304; SpecPlus_000870; I06-0117; MLS001304077; DivK1c_006966; Prestwick1_000558; gliclazide; NCGC00095107-06; Glimicron; Glyclazide; HMS1922D15; HMS1569P17; AKOS003237903; CHEBI:31654; Benzenesulfonamide, N-(((hexahydrocyclopenta(c)pyrrol-2(1H)-yl)amino)carbonyl)-4-methyl-; Gliclazide (JAN/INN); S 852; Bio-0502
Trade Name	Diamicron; Dianorm; Glubitor-OD
Indication	Diabetes mellitus			Approved    [1]
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
Therapeutic Class	Hypoglycemic Agents
CAS Number	CAS 21187-98-4
Formular	C15H21N3O3S
PubChem Compound ID	CID 3475.
PubChem Substance ID	SID 172641.
ChEBI	31654;
SuperDrug ATC ID	A10BB09;
SuperDrug CAS ID	021187984;
Target	SUR1-type K(ATP) channel			Blocker	[2][3]
Ref 1	Cefradine - FDA approved drug information (drug label) from DailyMed To Reference
Ref 2	Structural basis for the interference between nicorandil and sulfonylurea action. Diabetes. 2001 Oct;50(10):2253-9. To Reference
Ref 3	Pharmacological modulation of K(ATP) channels. Biochem Soc Trans. 2002 Apr;30(2):333-9. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.